RAS mutations confer an increased risk for relapse in patients with AML receiving induction chemotherapy Meeting Abstract


Authors: Ball, B.; Goldberg, A.; Tallman, M.; Stein, E.
Abstract Title: RAS mutations confer an increased risk for relapse in patients with AML receiving induction chemotherapy
Meeting Title: Acute Leukemias XVII: Biology and Treatment Strategies
Journal Title: Annals of Hematology
Volume: 98
Issue: Suppl. 1
Meeting Dates: 2019 Feb 24-27
Meeting Location: Munich, Germany
ISSN: 0939-5555
Publisher: Springer  
Date Published: 2019-02-01
Start Page: S42
End Page: S43
Language: English
ACCESSION: WOS:000459100600045
PROVIDER: wos
PUBMED: 30746560
DOI: 10.1007/s00277-019-03619-9
Notes: Meeting Abstract: 43 -- Title and authors are also listed on page S10 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Martin Stuart Tallman
    649 Tallman
  3. Aaron David Goldberg
    106 Goldberg
  4. Brian John Ball
    17 Ball